Soluble adhesion molecules in patients with breast cancer;Solubilní adhezní molekuly u pacientek s karcinomem mammy

Casopis Lekaru Ceskych

Volumn 142, Issue 5, 2003, Pages 292-299

  Tesařová, Petra ^a,b   Kvasnicka J ^a   Umlaufova A ^a   Homolkova J ^a   Kalousova M ^a   Tesar V ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Adhesion molecules; Breast cancer; CD44; E selectin; ICAM 1; P selectin; VCAM 1

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; CD44S ANTIGEN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; OROSOMUCOID; PADGEM PROTEIN; SOLUBLE ADHESION MOLECULE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER STAGING; CHEMOTHERAPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; POSTMENOPAUSE; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA; CELL ADHESION MOLECULES; FEMALE; HUMANS; MIDDLE AGED;

EID: 0038683267     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Adams, D. H., Mainolfi, E., Burra, P. et al.: Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases. Hepatology, 16, 1992, s. 810-814.
2. Aigner, S., Ramos, C. L., Hafezi-Moghadam, A. et al.: CD24 mediates rolling of breast carcinoma cells on P-selectin. FASEB J., 12, 1998, s. 1241-1251.
3. Ali, S., Kaur, J., Patel, K. D.: Intercellular cell adhesion molecule-1, vascular cell adhesion molcule-1, and regulated on activation normal T cell expressed and secreted are expressed by human breast carcinoma cells and support eosinophil adhesion and activation. Am. J. Pathol., 157, 2000, s. 313-321.
4. Antilla, M. A., Tammi, R. H., Tammi, M. I. et al.: High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Res., 60, 2000, s. 150-155.
5. Aruffo, A., Dietsch, M. T., Wan, H. et al.: Granule membrane protein 140 (GMP140) binds to carcinomas and carcinoma-derived cell lines. Proc. Natl. Acad. Sci. USA, 15, 1992, s. 2292-2296.
6. Banks, R. E., Gearing, A. J., Hemingway, I. K. et al.: Circulating intercellular adhesion molcule-1 (ICAM-1), E-selectin and vascular cell adhesion moelcule-1 (VCAM-1) in human malignancies. Br. J. Cancer, 68, 1993, s. 122-124.
7. Bevilacqua, M. P.: Endothelial-leukocyte adhesion molecules. Ann. Rev. Immunol., 11, 1993, s. 767-804.
8. Bhatavdekar, J. M., Patel, D. D., Shah, N. G. et al.: Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis. Ann. Surg. Oncol., 7, 2000, s. 305-311.
9. Bourguignon, L. Y., Zhu, H., Shao, L. et al.: CD44 interaction with tiaml promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration. J. Biol. Chem., 275, 2000, s. 1829-1838.
10. Budinsky, A. C., Brodowicz, T., Wiltschke, C. et al.: Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breast-cancer cells in vitro. Int. J. Cancer, 71, 1997, s. 1086-1090.
11. Byrne, G. J., Ghellal, A., Iddon, J. et al.: Serum soluble vascular adhesion molecule-1: role as a serum marker of angiogenesis. J. Natl. Cancer Inst., 16, 2000, s. 1329-1336.
12. Dippold, W., Wittrig, B., Schwaeble, W. et al.: Expression of intercellular adhesion molecule 1 (ICAM-1, CF54) in colonic epithelial cells. Gut, 34, 1993, s. 1593-1597.
13. Fogel, M., Friederichs, J., Zeller, Y. et al.: CD24 is a marker for human breast carcinoma. Cancer Lett., 23, 1999, s. 87-94.
14. Fox, S. B., Turner, G. D. H., Gatter, K. C. et al.: The increased expression of adhesion molecules ICAM-3, E- and P-selections on breast cancer endothelium. J. Pathol., 177, 1995, s. 369-376.
15. Friedrichs, K., Franke, F., Lisboa, B. W. et al.: CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Res., 55, 1995, s. 5424-5433.
16. Gearing, A. J. H., Hemingway, I., Pigott, R. et al.: Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1 and VCAM-1: pathological significance. Ann. NY Acad. Sci., 667, 1992, s. 324-331.
17. Grunberg, E., Eckert, K., Karsten, U. et al.: Effects of differentiation induces on cell phenotypes of cultured nontransformed and immortalized mammary epithelial cells: a comparative immunocytochemical analysis. Tumour Biol., 21, 2000, s. 211-223.
18. Gunthert, U., Hofmann, M., Rudy, W. et al.: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65, 1991, s. 13-24.
19. Guo, Y. J., Liu, G., Wang, X. et al.: Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res., 54, 1994, s. 422-426.
20. Harning, R., Mainolfi, E., Bystryn, J. C. et al.: Serum levels of circulating ICAM-1 in human malignant melanoma. Cancer Res., 51, 1991, s. 5003-5005.
21. Hebbar, M., Revillion, F., Louchez, M. M. et al.: The relationship between concentrations of circulating soluble E selectin and clinical, pathological, and biological features in patient with breast cancer. Clin. Cancer Res., 4, 1998, s. 373-380.
22. Hebbar, M., Revillion, F., Louchez, M. M. et al.: Prognostic value of circulating soluble E-selectin concentrations in node-negative breast cancer patients. Clin. Cancer Res., 5, 1999, s. 1427-1433.
23. Hebbar, M., Peyrat, J.P.: Significance of soluble endothelial molecule E-selectin in patients with breast cancer. Int. J. Biol. Markers, 15, 2000, s. 15-21.
24. Charpin, C., Garcia, S., Andrac, L. et al.: VCAM (IGSF) adhesion molecule expression in breast carcinoma detected by automated and quantitative immunocytochemical assays. Hum. Pathol., 29, 1998, s. 896-903.
25. Kainz, C., Tempfer, C., Winkler, S. et al.: Serum CD44 splice variants in cervical cancer patients. Cancer Lett., 90, 1995, s. 231-234.
26. Kaufmann, M., Heider, K. H., Sinn, H. P. et al.: CD44 variant exon epitopes in primary breast cancer and lenght of survival. Lancet, 345, 1995, s. 1706-1709.
27. Koch, A. E., Halloran, M. M., Haskell, C. J. et al.: Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature (Lond.), 376, 1995, s. 517-519.
28. Kuppner, M. C., Meir, E. V., Gauthier, T. H. et al.: Differential expression of the CD44 molecules in human brain tumors. Int. J. Cancer, 50, 1992, s. 572-577.
29. Lesley, J., Hyman, R., Kincade, P. W.: CD44 and its interaction with extracellular matrix. Adv. Immunol. 54, 1993, s. 271-335.
30. Lyzak, J. S., Yaremko, M. L., Recant, W. et al.: Role of CD44 in nonpalpable R1 a and T1b breast cancer. Hum. Pathol., 28, 1997, s. 772 až 778.
31. x antigens. Exp. Cell Res., 196, 1991, s. 20-25.
32. Matsuura, N., Narita, T., Mitsuoka, C. et al.: Increased concentrations of soluble E-selectin in the sera of breast cancer patients. Anticancer Res., 17, 1997, s. 1367-1372.
33. Moss, M. A., Zimmer, S., Anderson, K. W.: Role of metastatic potential in the adhesion of human breast cancer cells to endothelial monolayers. Anticancer Res., 20, 2000, s. 1425-1434.
34. Mulder, J.-W. R., Kruyt, P. M., Sew, N. et al.: Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet, 344, 1994, s. 1470-1472.
35. Naor, D., Sionov, R. V., Ish-Shalom, D.: CD44: Structure, function, and association with the malignant process. Adv. Cancer Res., 71, 1997, s. 241-319.
36. Nguyen, M., Corless, C. L., Kraling, B. M. et al.: Vascular expression of E-selectin is increased in estrogen- receptor negative breast cancer: a role for tumor-cell-secreted interleukin-1 alpha. Am. J. Pathol., 150, 1997, s. 1307-1314.
37. Ownby, H. E., Roi, L. D., Isenberg, R. R. et al.: Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer. Cancer, 52, 1983, s. 126-130.
38. Peterson, R. M., Yu, Q., Stamenkovic, I. et al.: Pertubation of hyaluronan interaction by soluble CD44 inhibit growth of murine mammary carcinoma cells in ascites. Am. J. Pathol., 156, 2000, s. 2159-2167.
39. Pigott, R., Dillon, R., Hemingway, I. H. et al.: Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem. Biophys. Res. Commun., 187, 1992, s. 584-589.
40. Pober, J. S., Gimbrone, M. A., Lapierre, L. A. et al.: Overlapping patterns of activation of human endothelial cells by interleukin-1, tumor necrosis factor and immune interferon. J. Immunol., 137, 1986, s. 1893 až 1896.
41. Regidor, P. A., Callies, R., Regidor, M. et al.: Expression of the cell adhesion molecules ICAM-1 and VCAM-1 in the cytosol of breast cancer tissue, benign breast tissue and corresponding sera. Eur. J. Gynaecol. Oncol., 19, 1998, s. 377-383.
42. Renkonen, J., Paavonen, T., Renkonen, R.: Endothelial and epithelial expression of sialyl (Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma. Int. J. Cancer., 20, 1997, s. 296-300.
43. Ristamaki, R., Joensuu, H., Salmi, M. et al.: Serum CD44 in malignant lymphoma: an association with treatment response. Blood, 84, 1994, s. 238-243.
44. Saddik, M., Lai, R.: CD44s as a surrogate marker for distinguishing intraductal papilloma from papillary carcinoma of the breast. J. Clin. Pathol., 52, 1999, s. 862-864.
45. Sheen-Chen, S. M., Chen, W. J., Eng, H. L. et al.: Evaluation of the prognostic value of serum soluble CD44 in patients with breast cancer. Cancer Invest., 17, 1999, s. 581-585.
46. Schneider, J., Pollan, M., Ruibal, A. et al.: Histologic grade and CD44 are independent predictors of axillar node invasion in early (T1) breast cancer. Tumour Biol., 20, 1999, s. 319-330.
47. Springer, T. A., Lasky, L. A.: Sticky sugars for selectins. Nature, 349, 1991, s. 196-197.
48. Stewart, R. J., Marsden, P. A.: Vascular endothelial cell activation in models of vascular and glomerular injury. Kidney Int., 45, 1994, s. S37 ai S44.
49. Tempfer, C., Losch, A., Heinzl, H. et al.: Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44 V6 and CD44 V7-8 in human breast cancer. Eur. J. Cancer, 32A, 1996, s. 2023 až 2025.
50. Tesařová, P., Kvasnička, J., Umlaufová, A. et al.: Solubilní receptory pro TNF a IL-2 u pacientů s karcinomem mammy. Čas. Lék. čcs., 137, 1998, s. 341-345.
51. Tesařová, P.,Kvasnička, J., Umlaufová, A. et al.: Proteiny akutní fáze u pacientek s karcinomem mammy. Sborn. Lék. (v tisku).
52. Tozeren, A., Kleinman, H. K., Grant, D. S. et al.: E-selectin-mediated dynamic interactions of breast and colon cancer cells with endothelial cell monolayers. Int. J. Cancer, 60, 1995, s. 426-431.
53. Wellicome, S. M., Kapahi, P., Mason, J. C. et al.: Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin. Exp. Immunol., 92, 1993, s. 412-418.
54. Ye, C. L., Ito, K., Kannagi, R. et al.: The significance of E-selectin in hematogenous metastasis of human colorectal cancer. Proc. Am. Assoc. Cancer Res., 36, 1995, s. 82.
55. Zetter, B. R.: Adhesion molecules in tumor metastasis. Semin. Cancer Biol., 4, 1993, s. 219-229.
56. Zhang, G. J., Adachi, I.: Serum levels of soluble intercellular adhesion molecule-1 and E-selectin in metastatic breast carcinoma: correlations with clinicopathological features and prognosis. Int. J. Oncol., 14, 1999, s. 71-77.